Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
Caroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2020
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Christophe Le Tourneau, Yungan Tao, Carlos Gomez-Roca, et al.
Clinical and Translational Science
|
March 20, 2021
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
Carlos Gomez-Roca, Caroline Even, Christophe Le Tourneau, et al.
Cancers
|
November 6, 2019
Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis
Jong Yeob Kim, Keum Hwa Lee, Jeonghyun Kang, et al.
Oncoimmunology
|
May 12, 2025
CD8<sup>+</sup> T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance
Carolina Abrate, Fernando P Canale, Sabrina N Bossio, et al.
Critical Care Medicine
|
April 23, 2020
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study
Virginie Lemiale, Stéphanie Pons, Adrien Mirouse, et al.
Scientific Reports
|
April 13, 2021
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
Cindy Neuzillet, Manon Marchais, Sophie Vacher, et al.
Oncoimmunology
|
October 27, 2023
CD39<sup>+</sup> conventional CD4<sup>+</sup> T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
Sabrina N Bossio, Carolina Abrate, Jimena Tosello Boari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2019
Immune gene expression in head and neck squamous cell carcinoma patients
Charlotte Lecerf, Maud Kamal, Sophie Vacher, et al.
British Journal of Cancer
|
August 26, 2020
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours
Christophe Le Tourneau, Jean-Pierre Delord, Nuria Kotecki, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
Caroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2020
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Christophe Le Tourneau, Yungan Tao, Carlos Gomez-Roca, et al.
Clinical and Translational Science
|
March 20, 2021
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
Carlos Gomez-Roca, Caroline Even, Christophe Le Tourneau, et al.
Cancers
|
November 6, 2019
Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis
Jong Yeob Kim, Keum Hwa Lee, Jeonghyun Kang, et al.
Oncoimmunology
|
May 12, 2025
CD8<sup>+</sup> T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance
Carolina Abrate, Fernando P Canale, Sabrina N Bossio, et al.
Critical Care Medicine
|
April 23, 2020
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study
Virginie Lemiale, Stéphanie Pons, Adrien Mirouse, et al.
Scientific Reports
|
April 13, 2021
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
Cindy Neuzillet, Manon Marchais, Sophie Vacher, et al.
Oncoimmunology
|
October 27, 2023
CD39<sup>+</sup> conventional CD4<sup>+</sup> T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade
Sabrina N Bossio, Carolina Abrate, Jimena Tosello Boari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2019
Immune gene expression in head and neck squamous cell carcinoma patients
Charlotte Lecerf, Maud Kamal, Sophie Vacher, et al.
British Journal of Cancer
|
August 26, 2020
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours
Christophe Le Tourneau, Jean-Pierre Delord, Nuria Kotecki, et al.
Page
of 6